• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!

作者信息

Peltekian Kevork Minas

机构信息

Division of Digestive Care & Endoscopy, Queen Elizabeth II Health Sciences Centre and Dalhousie University, 1276 South Park Street, Victoria General Building Room 9-915, Halifax, B3H 2Y9, NS, Canada.

出版信息

Ann Hepatol. 2020 Nov-Dec;19(6):583-584. doi: 10.1016/j.aohep.2020.07.011. Epub 2020 Aug 25.

DOI:10.1016/j.aohep.2020.07.011
PMID:32853777
Abstract
摘要

相似文献

1
For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!对于脂肪性肝病，是时候利用非侵入性纤维化检测来预测肝脏相关事件，而不仅仅是肝纤维化的组织学阶段了！
Ann Hepatol. 2020 Nov-Dec;19(6):583-584. doi: 10.1016/j.aohep.2020.07.011. Epub 2020 Aug 25.
2
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者中无创性纤维化模型预测轻度至中度纤维化的性能。
Liver Int. 2016 Apr;36(4):572-9. doi: 10.1111/liv.13054. Epub 2016 Jan 24.
3
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population.三种非侵入性纤维化评分（Hepamet、FIB-4、NAFLD 纤维化评分）在混合拉丁美洲人群中 NAFLD 患者中的诊断性能。
Ann Hepatol. 2020 Nov-Dec;19(6):622-626. doi: 10.1016/j.aohep.2020.08.066. Epub 2020 Sep 9.
4
13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的13C-美沙西汀呼气试验
Adv Clin Exp Med. 2016 Jan-Feb;25(1):77-81. doi: 10.17219/acem/60878.
5
Liver fibrosis markers of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的肝纤维化标志物
World J Gastroenterol. 2015 Jun 28;21(24):7427-35. doi: 10.3748/wjg.v21.i24.7427.
6
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.2016年非酒精性脂肪性肝病（NAFLD）的纤维化评估
Dig Dis Sci. 2016 May;61(5):1356-64. doi: 10.1007/s10620-016-4079-4. Epub 2016 Mar 26.
7
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.超高场磁共振波谱在非酒精性脂肪性肝病中的应用：非酒精性脂肪性肝炎和肝纤维化能量代谢的新机制和诊断见解。
Liver Int. 2017 Oct;37(10):1544-1553. doi: 10.1111/liv.13451. Epub 2017 May 20.
8
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
9
Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).非侵入性纤维化评分系统可预测非酒精性脂肪性肝病（NAFLD）患者未来的代谢并发症及总体死亡率。
Scand J Gastroenterol. 2019 Mar;54(3):328-334. doi: 10.1080/00365521.2019.1583366. Epub 2019 Mar 23.
10
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.新型非侵入性纤维化检测序贯组合可准确诊断非酒精性脂肪性肝病的晚期纤维化。
J Hepatol. 2019 Aug;71(2):389-396. doi: 10.1016/j.jhep.2019.04.020. Epub 2019 May 16.